You are here

Zontivity

With $25M-plus Aralez deal, Merck finds a buyer for abandoned clot-fighter Zontivity

Fierce Pharma

Sat, 09/10/16 - 09:48 am

Aralez Pharmaceuticals

Merck says Zontivity approved for reduction of thrombotic cardiovascular events

The Fly on the Wall

Wed, 05/21/14 - 11:16 am

thrombotic cardiovascular events

FDA approves Zontivity to lower heart attack, stroke risk in high-risk patients

The Fly on the Wall

Thu, 05/8/14 - 05:06 pm

Possible New Lease On Life For Two Cardiology Drugs From Merck And J&J

Forbes

Mon, 12/16/13 - 02:16 pm